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1. Introduction 
Glycogen synthetase (EC 2.4.1.11) is regulated 
through a phosphorylation-dephosphorylation me- 
chanism [l] . The dephosphorylated I-form is fully 
active in both the presence and absence of glucosed- 
phosphate, and can be converted to the phosphory- 
lated D-form, which has an absolute requirement for 
glucose&phosphate, by incubation with magnesium 
ions, ATP and the cyclic AMP dependent protein 
kinase which also activates phosphorylase kinase [2,3] 
The proportion of glycogen synthetase D in skeletal 
muscle is increased by the administration of adrenalin 
[4] . This presumably acts through the elevation in 
cyclic AMP levels [ 5,6] and activation of cyclic AMP 
dependent protein kinase [7] which have been shown 
to occur in vivo in response to the hormone. 
The reconversion of glycogen synthetase D to I is 
under the control of insulin [8] , but it appears to be 
independent of the effect of this hormone on glucose 
transport into muscle [4] . It is also unlikely that the 
effect is explainable in terms of an inactivation of cy- 
clic AMP dependent protein kinase resulting from a 
decreased availability of cyclic AMP, because cyclic 
AMP levels in muscle not only do not decrease in the 
presence of insulin, but even show a slight rise [9]. 
Theoretically, the elevation of synthetase I levels 
by insulin could be achieved in one of three different 
ways. Insulin could increase the activity of glycogen 
synthetase phosphatase, decrease the activity of cyclic 
AMP dependent protein kinase, or change the confor- 
mation of glycogen synthetase itself, rendering it a 
better substrate for the phosphatase or a less effective 
substrate for the kinase. Since an investigation of these 
possibilities required the use of both the D and I forms 
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as substrates for the interconverting enzymes, a detailed 
study was undertaken of the phosphorylation of glyco- 
gen synthetase I in vitro. This has led to the discovery 
reported here, that glycogen synthetase preparations 
contain a new protein kinase, distinct from cyblic AMP 
dependent protein kinase and phosphorylase kinase, 
which is able to phosphorylate glycogen synthetase. 
The possible relationship between this new enzyme, 
termed glycogen synthetase kinase 2 (GSK 2) and the 
mechanism of action of insulin is discussed. 
2. Materials and methods 
2.1. Enzymes 
Glycogen synthetase was isolated from rabbit skeletal 
muscle [lo] . The preparation was essentially homoge- 
neous by the criterion of dodecyl sulphate gel electroph- 
oresis, and was greater than 9.5% in the I-form as judged 
by assays in the presence and absence of glucosed-phos- 
phate. Phosphorylase kinase and cyclic AMP dependent 
protein kinase (peak II from DEAE-cellulose) were 
purified from skeletal muscle as described previously 
[ 1 l] . The protein inhibitor of cyclic AMP dependent 
protein kinase was partially purified up to the 1% 
trichloroacetic acid precipitation step [ 121 , Histone 
F1 from rabbit liver was a generous gift from Profes- 
sor Thomas Langan, University of Denver. 
2.2. Protein phosphorylation 
Reactions were carried out at pH 7.0,2O”C in the fols 
lowing incubation mixture: sodium glycerophosphate 
10 mM, EDTA 0.4 mM, [Y-~~P] ATP or GTP as indi- 
cated, and protein substrate 0.006-0.012 mM 
(glycogen synthetase, phosphorylase kinase or histone 
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F,). Magnesium acetate was normally present in a ten 
fold excess over the nucleoside triphosphate, but for 
experiments in which initial rates of phosphorylation 
were measured, the free ma~esium ion concentration 
was maintained at 10 mM. Where indicated, cyclic 
AMP (0.001 mM), cyclic AMP dependent protein - 
kinase, and the inhibitor protein were also included. 
The reactions were initiated with the nucleoside 
t~phosphate, and aliquots were removed at various 
times, and analysed for the total covalently bound 
phosphate incorporated [ 13 J . In calculating the stoi- 
chiometry of phosphate incorporation, one mole of 
glycogen synthetase was taken as 88 000 g (the subunit 
molecular weight determined by gel electrophoresis 
[lo] , one mole of histone F 1 as 2 1 000 g, and one 
mole of phosphorylase kinase as the @3y unit or 
3 18 000 g of protein [ 111. The absorbance index, 
A:$$, of glycogen synthetase was taken as 13.5 [lo] 
and that of phosphorylase kinase as 12.4 [I I]. The 
initial rate of phosphorylation of each protein was 
found to be linear up to an incorporation of 0.1 moles 
of phosphate per mole protein. 
In order to use 32 P-labelled glycogen synthetase 
as a substrate for trypsin, reactions were terminated 
by the addition of EDTA to 15 mM and ammonium 
sulphate to 45% saturation. The solutions were stored 
for 30 min at 0°C and then centrifuged at 18 000 g 
for ten min. The precipitates were washed once with 
45% ammonium sulphate, EDTA 1 .O mM pH 7.0, 
redissolved in Tris-HCl buffer 50 mM pH 7.5 contain- 
ing EDTA 1 .O mM and dithiothreitol 1 .O mM, and 
dialysed against this buffer overnight at 4°C. 
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3. Results 
3.1. Phospho~lution of glycogen synthetase by endo- 
genous protein kinases 
Incubation of purified glycogen synthetase or 
phosphorylase kinase with magnesium ions and 
[T-~‘P] ATP led to a slow incorporation of radioacti- 
vity into each protein, which was markedly st~ulated 
by the addition of cyclic AMP (fig. 1). This showed 
that each preparation was contaminated with trace 
amounts of cyclic AMP dependent protein kinase. The 
endogenous activity was however not completely 
supressed by the addition of the specific protein inhi- 
bitor of cyclic AMP dependent protein kinase. In the 
case of phosphorylase kinase, the residual activity is 
thought to arise from the self phospho~lation of 
phosphorylase kinase catalysed by the enzyme itself 
[ 131. In the case of glycogen synthetase however, a 
similar interpretation did not seem likely, and the re- 
sults suggested that the glycogen synthetase prepara- 
tions mi$tt be cont~inated with a protein kinase 
distinct from the cyclic AMP dependent enzyme. This 
idea was tested by using the inhibitor protein to ti- 
trate the phosphorylation of histone catalysed by cy- 
clic AMP dependent protein kinase and the endogenous 
phospho~lation of glycogen synthetase (fig. 2). It can 
be seen, that, whereas the phosphorylation of histone 
could be almost totally suppressed by the inhibitor 
protein, the endogenous phosphorylation of glycogen 
synthetase showed a component, accounting for about 
50% of the total phospho~lation rate at 0.2 mM ATP, 
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Fig. 1. Phosphorylation of (A) glycogen synthetase and (B) phosphorylase kinase by endogenous protein kinases upon addition of 
ATP to a final concentration of 0.2 mM. The reactions were carried out with cyclic AMP (0.001 mM) in the presence (o) or absence 
(v) on inhibitor protein 60 kg/ml, or without cyc.Iic AMP in the presence (*) or absence (T) of inhibitor protein. The other reaction 
conditions are as given under Materials and methods. 
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Fig. 2. The effect of inhibitor protein on the phosphorylation of (A) histone F, and (B) glycogen synthetase. The reaction condi- 
tions were: (A) histone 0.25 mg/ml, cyclic AMP (0.001 mM), purified cyclic AMP dependent protein kinase: (B) glycogen synthetase 
0.01 mg/ml, cyclic AMP 0.001 mM). Each reaction.was initiated with ATP to a final con~~tration of 0.2 mM, and graphs show the 
initial rates of 3zP incorporation (moles/mole protein) plotted as a function of inhibitor protein concentration. 
which was completely unaffected by the inhibitor 
protein. 
Analysis of glycogen synthetase preparations showed 
a cont~ination with phospho~lase kinase of about 
0.5% by weight. However, addition of purified phospho- 
rylase kinase to increase this activity ten fold had no 
in~uence on the rate of phospho~lation of glycogen 
synthetase. Similarly, ethyleneglycol bis(2-aminoethyl 
ether)&, N’ tetracetic acid (EGTA) 0. l-l .O mM which 
inhibits phosphorylase kinase, and calcium ions (O.l- 
1 .O mM) and glycogen (6 mg/ml) which activate phos- 
phorylase kinase [ 14-161 did not affect the rate of 
phosphorylation of glycogen synthetase in the presence 
or absence of inhibitor protein. This indicated that a 
new protein kinase distinct from cyclic AMP dependent 
protein kinase and phosphorylase kinase was present as 
a trace contaminant in glycogen synthetase preparations. 
This enzyme is termed glycogen synthetase 2 (GSK 2) 
to distinguish it from cyclic AMP dependent protein 
kinase, which can be regarded as GSK 1. 
3.2. Properties of glycogen synthetase kinase 2 
The nucleoside triphosphate specificity of GSK 2 
was examined by studying the endogenous phosphory- 
lation of ~y~ogensyn~etase in the presence of the 
inhibitor protein at 60pg/ml. The JCm values for ATP 
and GTP were found to be 0.4 mM and 5.0 mM respec- 
tively, and approximately the same maximal reaction 
velocity was found in each case. Under equivalent 
conditions, the Ilr, of cyclic AMP dependent protein 
kinase for ATP was 0.024 mM, but this enzyme did 
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not give a measurable rate of phosphorylation of gly- 
cogen synthetase when GTP was used as the phospho- 
ryl donor. 
In the presence of the i~ibitor protein, and either 
ATP 2 mM or GTP IO mM, the incorporation of 32P 
by endogenous GSK 2 reached a plateau at 0.4-0.5 
moles of phosphate per mole protein. The incorpora- 
tion. did not affect the activity of the enzyme which 
remained in the I-form throughout. This contrasted 
with the phospho~lation of glycogen synthetase by 
exogenous cyclic AMP dependent protein kinase, which 
rapidly reached a plateau after the incorporation of 
1 .O + 0.1 moles per mole protein, and converted gly- 
cogen synthetase I to D [ 10,2] . 
3.3. Tryptic digestion of 32P-labelled glycogen synthe- 
tase 
Glycogen synthetase was maximally phospho~lat- 
ed by the action of either added cyclic AMP dependent 
protein kinase at 0.1 mM ATP, or by endogenous GSK 
2 at 2 mM ATP in the presence of the inhibitor protein. 
Each preparation was then incubated with trypsin at a 
1: 1 molar ratio at pH 7.5, and the liberation of . 
trichloroacetic acid soluble ‘*P-labelled peptides was 
analysed as a function of tire. When glycogen synthe- 
tase labelled with cyclic AMP dependent protein kinase 
was used, there was an extremely rapid release of 321?- 
labelled peptides, which reached a plateau within a few 
minutes. However, with giycogen synthetase iabelled 
using GSK 2 only l-2% of the radioactivity was releas- 
ed in 5 min under equivalent conditions (fig. 3). Only 
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Fig. 3. Digestion of native a2 P-labelled glycogen synthetase 
(2.6 mg/ml) with trypsin (0.7 mg/ml). The graph shows the 
release of trochloroacetic acid soluble tryptic peptides at 
20°C from glycogen synthetase phosphorylated with cyclic 
AMP dependent protein kinase (o) or GSK 2 (*), as a func- 
tion of time. Glycogen synthetase was phosphorylated 
either in the presence of 0.1 mM ATP with 0.001 mM 
cyclic AMP and added cyclic AMP dependent protein kinase 
(o), or by endogenous GSK 2 in the presence of 2 mM ATP 
and inhibitor protein 60 g/ml (0). The preparations contain- 
ed 0.95 moles 3a?/mole protein at zero time (0) or 0.43 moles 
32 P/mole (0). 
10% of the radioactivity became acid soluble after 
incubation with trypsin for 60 min, although 80% 
solubilisation could be achieved in 60 min, by digestion 
with chymotrypsin at a 1: 1 molar ratio (not illustrated). 
These results clearly showed that the two protein kinases 
had labelled different sites on glycogen synthetase. 
4. Discussion 
The results establish the existence in skeletal muscle 
of a new protein kinase activity, termed GSK 2, which 
can phosphorylate glycogen synthetase. GSK 2 is not 
phosphorylase kinase, and can be distinguished from 
cyclic AMP dependent protein kinase on five counts: 
(1) it is not activated by cyclic AMP; (2) it is not 
inhibited by the inhibitor protein; (3) it does not ap-. 
pear to promote the conversion of glycogen synthetase 
I to D; (4) it has a different nucleoside triphosphate 
specificity; (5) it labels different site(s) on glycogen 
synthetase. GSK 2 phosphorylation ‘plateaus’ at lower 
than stoichiometric amounts: this may arise as a con- 
sequence of the low amount of endogenous GSK 2 
activity present in the synthetase preparations or 
possibly because the site(s) labelled by GSK 2 are al- 
ready partially phosphorylated. 
The identification of GSK 2 at least partially ex- 
plains the wide discrepancy in the content of phos- 
phate bound covalently to glycogen synthetase D 
which has been reported previously [2,17]. Incubat- 
ion of purified synthetase I with purified cyclic AMP 
dependent protein kinase at 0.6 mM ATP was report- 
ed to be accompanied by the rapid conversion to gly- 
cogen synthetase D and incorporation of close to one 
mole of phosphate per mole enzyme [ 21, in agree- 
ment with the present data. However, preparations 
of synthetase D which had been phosphorylated at 
an early stage in the purification by a prolonged 
three day incubation at 3°C with 10 mM ATP were 
found to contain six moles of phosphate per mole 
protein [ 171. In this case at least some of the extra 
phosphate probably resulted from the combined 
action of the two endogenous protein kinases which 
label different sites on the enzyme. 
When assayed under optimal conditions (i.e. high 
ATP), endogenous GSK 2 activity in purified glyco- 
gen synthetase preparations is about three times 
greater than endogenous cyclic AMP dependent 
protein kinase activity. Cyclic AMP dependent 
protein kinase is an extremely active enzyme, and 
is potentially capable of converting glycogen synthetase 
Z to D within a few seconds in vivo. Since the purifica- 
tion of glycogen synthetase enriches the enzyme relative 
to cyclic AMP dependent protein kinase by a factor of 
more than 200, these results suggest hat the activity of 
GSK 2 in muscle extracts is also likely to be appreciable. 
Furthermore, skeletal muscle extracts contain a protein 
phosphatase activity which catalyses the dephosphory- 
lation of the site(s) labelled by GSK 2 at a rate as fast 
as or faster than that of the site(s) labelled by cyclic 
AMP dependent protein kinase (J. F. Antoniw, H. G. 
Nimmo and P. Cohen, unpublished experiments). It is 
therefore of interest to speculate about the possible 
role of GSK 2 phosphorylation. 
Two cases are now known to exist in which protein 
function is regulated by multiple phosphorylations. The 
control of phosphorylase kinase activity by cyclic AMP 
dependent protein kinase involves the phosphorylation 
of the enzyme at two sites. The phosphorylation of the 
second site does not affect the activity of the enzyme 
directly, but greatly enhances the rate of dephosphory- 
lation of the primary site and hence inactivation of the i 
enzyme [ 181; moreover, the phosphorylation of both 
sites occurs in vivo in response to adrenalin [7] . Second- 
ly , it has been demonstrated that histone F , is phospho- 
165 
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rylated in vivo by two distinct protein kinases. One of 
these is the cyclic AMP dependent protein kinase [ 191, 
and the other is a kinase, present only in growing cells, 
which phosphorylates the protein at sites distinct from 
that labelled by cyclic AMP dependent protein kinase 
[ 201 . Phosphorylation of histone F 1 by either kinase 
influences its interaction with DNA (T. A. Langan, 
personal communication). The recent discovery that 
insulin stimulates the phosphorylation of a 140 000 
mol. wt. component in adipose tissue [21] suggests 
that the activation of a protein kinase may underlie the 
actions of insulin, as appears to be the case for adrena- 
lin. It seems possible that GSK 2 is under the control 
of insulin and induces a functional alteration in gly- 
cogen synthetase which facilitates the conversion of 
glycogen synthetase D to I. The isolation of GSK 2 
and an assessment of this possibility are in progress 
in this laboratory. 
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